A 56-year-old patient came in for a hormone consultation and spent the first fifteen minutes talking about energy and sleep before he got to the reason he had actually booked. His chest had changed. Over a couple of years it had softened and filled out, more on one side than the other, and he had stopped taking his shirt off at the lake. He wanted to know whether this was just the weight he had put on, whether the medication his cardiologist had started was involved, and — the question under the question — whether it was something to worry about. He had been turning it over privately for a long time before saying it out loud.
That visit is common, and the reluctance is the part I want to address first. Enlarged breast tissue in men is one of the more quietly distressing changes I see in midlife, and men tend to sit with it far longer than they should because it feels embarrassing to raise. It is worth raising. It is common, it is evaluable, and in most cases the causes are understandable and the path forward is clear once someone actually examines it and runs the right workup.
Glandular tissue versus chest fat: a distinction you can feel
The single most important step is one that happens on examination, and it reorganizes everything that follows. There are two different things men are describing when they point to their chest, and they are not the same problem.
True gynecomastia is glandular tissue — the growth of actual breast gland behind and around the nipple. On exam it feels like a firm, rubbery, discrete disc of tissue centered under the nipple, often tender, sometimes present on one side more than the other. Pseudogynecomastia is fat: soft, more evenly distributed across the chest, without that distinct disc of firm tissue underneath. Plenty of men have a mix of the two, which is part of why it is confusing from the outside.
You can get a rough sense of it yourself — glandular tissue feels like a firm button behind the nipple, fat feels uniform and soft — but the reliable version of this distinction is a clinical exam. It is worth getting right, because the entire management plan branches off it.
Why the distinction matters
It matters because the two have different causes and different fixes. Fatty enlargement is a body-composition issue, and it responds to the things that change body composition — losing fat reduces it. Glandular tissue is a hormonally driven structural change, and losing weight does not make established gland disappear. A man who is told "just lose some weight" when his problem is a firm disc of glandular tissue will do the work, see the fat around it shrink, and find the core lump still sitting there — and he will reasonably conclude the advice was wrong, because for his situation it was incomplete. Sorting glandular from fatty at the start is what keeps the plan honest.
The midlife mechanism: the testosterone-to-estradiol shift
The hormonal story behind midlife glandular gynecomastia is, at its core, a balance problem between two hormones. Breast gland tissue is stimulated by estrogen and restrained by androgen. What decides whether gland grows is less any single number and more the ratio between testosterone and estradiol.
Two things tend to move that ratio the wrong way in midlife. First, testosterone declines gradually with age — the slow transition I described in the andropause article. Second, body fat tends to rise, and fat tissue is metabolically active: it contains aromatase, the enzyme that converts testosterone into estradiol. So as a man gains fat, more of his testosterone is being converted into estrogen, at the same time his testosterone production is drifting down. Less androgen, relatively more estrogen — the ratio tilts toward the signal that stimulates gland.
This is also why the lab picture is more informative than most men have been shown. A total testosterone that looks "normal" does not tell you what fraction is free and active, what the estradiol is doing, or how the binding proteins are shaping the ratio. I walked through why total testosterone alone is an incomplete number in the free-versus-total testosterone article, and the estrogen side of the equation — which estrogen, measured how — in the three estrogens explainer. For gynecomastia specifically, estradiol should be read by a sensitive (LC-MS/MS) method, because the routine immunoassay tends to read unreliably at the low estradiol levels men typically run.
The medications that can be involved
A number of medications carry well-established associations with gynecomastia, and this is one of the highest-yield parts of the history. The ones I ask about directly:
Spironolactone is near the top. It is widely prescribed for blood pressure and heart failure, and it has anti-androgen activity — it blunts the androgen side of the ratio, which is exactly the wrong direction. The 5-alpha-reductase inhibitors, finasteride and dutasteride, used for prostate enlargement and male-pattern hair loss, are also on the list. Cimetidine, an older heartburn medication, has a documented association. Several cardiac and psychiatric medications can contribute. And anabolic steroid use — including the "testosterone" bought outside a monitored medical setting — is a frequent and often unspoken cause, because supraphysiologic dosing drives heavy aromatization.
The point of naming these is not to tell anyone to stop a medication. Some of these drugs are doing important work that should not be interrupted casually. The point is that the medication list has to be reviewed carefully, because when a medication is a meaningful contributor, that changes the plan — sometimes in coordination with the prescribing clinician there is an alternative, and sometimes the right answer is to account for the medication rather than change it.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
Alcohol and the liver
Alcohol deserves its own mention. Regular heavier drinking contributes to gynecomastia through more than one route: it affects the testes' testosterone production, and it burdens the liver, which is central to clearing hormones from the body. When the liver is not metabolizing estrogen efficiently, estrogen exposure effectively rises. I keep this qualitative rather than putting numbers on it, because the effect scales with the individual picture, but the liver's broader role in hormone and metabolic balance is real and underappreciated — I touched on it in the liver's role in weight management. For some men, an honest look at alcohol intake is one of the more useful modifiable levers in the whole assessment.
The red flags worth prompt evaluation
I want to state this part calmly, because the goal is proper evaluation, not alarm. The large majority of gynecomastia is benign. But certain features are worth prompt attention — usually benign, and checked properly rather than assumed.
Enlargement on one side only. Tissue that feels hard or fixed rather than soft and rubbery. Any discharge from the nipple. Changes in the overlying skin, or dimpling. A rapid change over a span of weeks rather than a slow shift over years. None of these features means something is wrong. Male breast cancer is uncommon. But these are exactly the situations where the right move is imaging and a proper exam instead of watchful waiting, because the value of a prompt look is that it either finds something early or, far more often, lets everyone stop wondering. If any of these describe your situation, that is a reason to be seen sooner rather than later.
The honest management map
Once glandular and fatty components are sorted and the workup is in hand, the plan follows the mechanism.
Weight loss is the first lever for the fatty component, and it does double duty: it directly reduces pseudogynecomastia, and by shrinking fat mass it lowers aromatase activity, which helps the hormonal ratio going forward. For many men, structured medical weight loss resolves the bulk of what they were seeing. What it will not do is dissolve established glandular tissue — that structure does not respond to fat loss.
Medication review comes next, handled as above — identifying contributors and coordinating any change with the prescriber rather than acting unilaterally.
Hormonal evaluation is where the ratio gets addressed directly, and this is where I have to be careful and honest about testosterone therapy. Men understandably assume that if testosterone is low and gynecomastia is an estrogen-driven problem, then adding testosterone must be the fix. It is not that simple, and in some men it makes glandular tissue worse. Added testosterone is substrate for aromatase, and in a man who aromatizes readily, raising testosterone can raise estradiol along with it and stimulate the very tissue involved. When men's hormone therapy is genuinely appropriate for a documented deficiency, it is done with estradiol monitored and managed as part of a deliberate, conservative protocol — not as a blunt attempt to treat the chest. Raising testosterone is not, by itself, a treatment for gynecomastia, and anyone who frames it that way is skipping the part that matters.
When glandular tissue is established and persistent — present after weight loss, after the medication picture is addressed, after the hormonal balance is optimized — the definitive answer is surgical, and that means a referral. We do not perform gynecomastia surgery here; what we do is the medical workup that determines whether surgery is actually what you need, so that a man does not go under anesthesia for tissue that would have responded to a medication change or a hormonal correction, and does not spend two more years on hormonal management for a firm disc of gland that was only ever going to resolve with a procedure.
The embarrassment factor, handled with dignity
I come back to where the visit usually starts, which is a man who has been carrying this quietly. There is nothing about gynecomastia that should be embarrassing to raise, and yet it consistently is, and I would rather name that than pretend it away. The changes it produces are visible enough to affect how a man dresses, whether he takes his shirt off, and how he feels in his own body, and those are real quality-of-life effects that deserve a real evaluation rather than a joke or a shrug.
The men I see are frequently surprised by how ordinary the conversation turns out to be — a history, an exam, a lab panel, and a clear explanation of which of the several possible mechanisms is driving their particular picture. It is common, it is understandable, and it is worth the visit. The aesthetic side of men's care in general is one I think deserves more attention than it gets, which is a theme I wrote about in the men's aesthetics article.
Your concrete next step
If your chest has changed and you have been quietly wondering about it, a comprehensive workup is what sorts it out. Book a private consultation at the Columbus location or in Warner Robins — the same protocol at both. Bring your full medication list, including anything bought outside a clinic, and any recent labs. The visit sorts glandular tissue from fat, runs the hormonal panel with estradiol measured properly, reviews the medication and alcohol picture, and — if any of the features that warrant prompt imaging are present — moves on that first. From there the plan is built on your actual mechanism, whether that is weight and metabolic work, a hormonal correction done carefully, a coordinated medication change, or a surgical referral for tissue that needs it. The point of the visit is a clear answer, which is a better place to be than another year of wondering.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Gynecomastia can have benign and, rarely, serious causes, and any new or changing breast tissue in a man should be evaluated in person. No medication should be started, stopped, or changed without the involvement of the prescribing clinician. Individual results vary. Consult a qualified healthcare provider before making treatment decisions.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.